Another study of Chinese NAFLD individuals reported that the deletion of carboxylesterase 1 (CES1) CNV was associated with NAFLD risk (OR: 2.75) [185]. This evidence concerns the gene CES1 and metabolic dysfunction-associated steatotic liver disease.